XML 36 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Cash flow from operating activities:    
Net (loss) income $ (137,938) $ 88,183
Adjustments to reconcile net (loss) income to cash flow used in operating activities:    
Depreciation and amortization 64,085 56,909
Share-based compensation 14,070 9,860
Excess tax benefits from share-based compensation (378) (1,705)
Devaluation of Venezuelan balance sheet 1,584 0
Gain on sale of assets, net (3,421) (397)
Impairment of assets 70,642 14,631
Equity in earnings of an investee 0 (702)
Cash flow from changes in certain assets and liabilities:    
Trade receivables (41,789) (49,683)
Inventories (79,492) (55,397)
Prepaid expenses 11,481 (1,698)
Prepaid income taxes (20,987) 3,823
Other current assets (42,544) (28,049)
Accounts payable (10,660) (2,013)
Deferred revenue 5,168 (34,053)
Deferred income tax 40,164 2,480
Certain other assets and liabilities 70,973 (30,945)
Net cash used in operating activities (59,042) (28,756)
Cash flow from investing activities:    
Payments for acquisitions, net of cash acquired 0 23,625
Proceeds from maturities of investments 379,889 261,817
Proceeds from sale of investments 22,711 33,437
Payments for purchases of investments (363,710) (299,265)
Proceeds from sale of assets 4,353 1,851
Capital expenditures (25,648) (35,856)
Collections on purchased finance receivables 6,105 12,296
Increase in certain other assets (10,006) (9,105)
Net cash provided by (used in) investing activities 13,694 (58,450)
Cash flow from financing activities:    
Dividends paid (55,469) (54,573)
Revolving debt borrowings, net 11,007 139,000
Other debt borrowings 38,591 94,602
Other debt repayments (112,140) (139,269)
Distributions of affiliates earnings to noncontrolling interest holders (6,380) (2,092)
Excess tax benefits from share-based compensation 378 1,705
Issuance of common shares 10,264 16,651
Repurchase of common shares (3,660) (3,076)
Net cash (used in) provided by financing activities (117,409) 52,948
Effect of exchange rate changes on cash and cash equivalents (114) 2,888
Decrease in cash and cash equivalents (162,871) (31,370)
Cash and cash equivalents at the beginning of the period 368,792 333,920
Cash and cash equivalents at the end of the period 205,921 302,550
Significant noncash investing activities: Accrued holdback for acquisition $ 0 $ 15,000